Highlighted Publications:

Heltemes-Harris LM, Larson JD, Starr TK, Hubbard GK, Sarver AL, Largaespada DA, Farrar MA. Sleeping Beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia. Oncogene. 2016 Jun 30;35(26):3454-64.

Katerndahl CDS, Heltemes-Harris LM, Willette MJL, Henzler CM, Frietze S, Yang R, Schjerven H, Silverstein KAT, Ramsey LB, Hubbard G, Wells AD, Kuiper RP, Scheijen B, van Leeuwen FN, Müschen M, Kornblau SM, Farrar MA. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival. Nat Immunol. 2017 Jun;18(6):694-704.

Regan Anderson TM, Peacock DL, Daniel AR, Hubbard GK, Lofgren KA, Girard BJ, Schörg A, Hoogwijs D, Wenger RH, Seagroves TN, Lange CA.  Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression. Cancer Res. 2013 Sept; 73(18):5810-20.

Lofgren KA, Ostrander JH, Housa D, Hubbard GK, Locatelli A, Bliss RL, Schwertfeger KL, and Lange CA. Mammary Gland Specific Expression of Breast Tumor Kinase (Brk/Ptk6) Promotes Delayed Involution and Tumor Formation Associated with Activation of p38 MAPK. Breast Cancer Research. 2011 Sept 17; 13(5): R89.

The views and opinions expressed in this page are strictly those of the page author.

The contents of this page have not been reviewed or approved by the University of Minnesota.